SANOTIZE
SaNOtize is a biotech company using a platform technology for topical to treat upper respiratory and dermal infections. The company develops a Nitric Oxide Releasing Solution platform technology to treat and prevent microbial infections, including drug resistant microbes. Its target indications include treatment for strep throat, athlete's foot, infected wounds, diabetic foot ulcers, sinusitis, cold and flu, and others. SaNOtize was founded in 2017 by Gilly Regev and Chris Miller and it is headquartered in Vancouver, British Columbia.
SANOTIZE
Industry:
Biotechnology Life Science Medical
Founded:
2017-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.sanotize.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
26.5 M USD
Technology used in webpage:
SPF LetsEncrypt ReCAPTCHA IIS 10 Microsoft Gravity Forms
Similar Organizations
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Current Advisors List
Current Employees Featured
Founder
Investors List
OurCrowd
OurCrowd investment in Series B - SaNOtize
Agricultural Bank of China
Agricultural Bank of China investment in Series B - SaNOtize
Horizons Ventures
Horizons Ventures investment in Series B - SaNOtize
OurCrowd
OurCrowd investment in Series A - SaNOtize
Angel Forum
Angel Forum investment in Angel Round - SaNOtize
Official Site Inspections
http://www.sanotize.com Semrush global rank: 2.09 M Semrush visits lastest month: 9.87 K
- Host name: 107-161-37-50.ptr.fhdns.net
- IP address: 107.161.37.50
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "SaNOtize"
Our Company - SaNOtize
The Company SaNOtize, based in Vancouver, Canada, is developing and commercializing products that deliver the natural antimicrobial properties of nitric oxide (NO) for use in common viral, bacterial, and fungal infections. SaNOtize …See details»
SaNOtize - Crunchbase Company Profile & Funding
SaNOtize is a biotech company using a platform technology for topical to treat upper respiratory and dermal infections. The company develops a Nitric Oxide Releasing Solution platform …See details»
Board of Directors - SaNOtize
Elaine Campbell A retired senior executive with over 30 years of experience in the pharmaceutical and chemical industry, Elaine has broad commercial experience in sales and marketing, …See details»
SaNOtize - Funding, Financials, Valuation & Investors - Crunchbase
SaNOtize is a biotech company using a platform technology for topical to treat upper respiratory and dermal infections. Search Crunchbase. Start Free Trial . ... How much funding has this …See details»
SaNOtize to Evaluate Nitric Oxide Nasal Spray for the Treatment of ...
Feb 13, 2024 SaNOtize has begun enrollment of 186 patients in a Phase 2 study in Canada that will assess the safety and efficacy of NONS compared to placebo as a treatment for RARS. …See details»
Vancouver company’s anti-COVID-19 nasal spray to …
Jan 11, 2021 A Vancouver-based company called SaNOtize has created a nasal spray that it says can stop COVID-19 from spreading throughout the body and even prevent someone from getting the virus. “The ...See details»
SaNOtize Obtains Health Canada Approval to Begin Enrolment for …
Jun 23, 2021 The SaNOtize treatment is based on nitric oxide (NO), a natural nanomolecule produced by the human body with proven anti-microbial properties shown to have a direct …See details»
SaNOtize Announces $24 Million in Series B Funding to Advance …
Aug 24, 2022 About SaNOtize SaNOtize Research & Development Corp. is a pharmaceutical company based in Vancouver, BC, commercializing the multi-faceted antimicrobial properties …See details»
Newly Published Phase 3 Study in People with COVID-19 Shows …
Jul 13, 2022 About SaNOtize. SaNOtize Research & Development Corp. is a pharmaceutical company based in Vancouver, BC, commercializing the multi-faceted antimicrobial properties …See details»
Sanotize Obtains Health Canada Approval To Begin Enrolment For …
Jun 23, 2021 VANCOUVER, BC–(BUSINESS WIRE)–SaNOtize Research and Development Corporation (“SaNOtize” or “the company”) announced that it has received approval from …See details»
Our Technology - SaNOtize
SaNOtize’s key innovation is the development of solutions that locally release nitric oxide (NO) in concentrations with potential antimicrobial effects against viruses, bacteria, and fungi. Nitric …See details»
SaNOtize moves to carve new OTC market for COVID therapy
Jul 25, 2022 SaNOtize's plan now will be to launch a phase 3 trial in the U.S. sometime in October, either by initiating a brand-new study or expanding a trial already ongoing in Canada. …See details»
We want to be a product approved for Canadians: SaNOtize CEO …
U.K. clinical trials for Vancouver’s SaNOtize have confirmed that its nasal spray reduced SARS-CoV-2 log viral load by more than 95 per cent in infected part...See details»
Clinical Study Suggests SaNOtize Nitric Oxide Nasal Spray Is …
May 11, 2022 About SaNOtize. SaNOtize Research & Development Corp. is a pharmaceutical company based in Vancouver, BC, commercializing the multi-faceted antimicrobial properties …See details»
Clinical Study Suggests SaNOtize Nitric Oxide Nasal Spray Is …
May 11, 2022 In India, NONS received an emergency use approval by the Central Drugs Standard Control Organization (CDSCO) for treatment of adult patients with COVID-19 who …See details»
SaNOtize Obtains Health Canada Approval to Begin Enrolment for …
Jun 23, 2021 SaNOtize Research and Development Corporation (“SaNOtize” or “the company”) announced that it has received approval from Health Canada to proceed with enrollment of …See details»
UK Clinical Trial Confirms SaNOtize’s Breakthrough Treatment for …
Mar 15, 2021 About SaNOtize SaNOtize Research & Development Corp. is a biotech company based in Vancouver, BC working to commercialize the multi-faceted antimicrobial properties of …See details»
SaNOtize Ramps Up Anti-COVID Nasal Spray Production To Keep …
Nov 30, 2021 SaNOtize CEO Dr. Gilly Regev visited Israel earlier this month as she inspected the increase in manufacturing production of her company’s antiviral nasal spray, Enovid, which …See details»
Phase 3 Clinical Trial Confirms SaNOtize’s ... - Business Wire
Feb 9, 2022 About SaNOtize. SaNOtize Research & Development Corp. is a pharmaceutical company based in Vancouver, BC, commercializing the multi-faceted antimicrobial properties …See details»